These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11279593)

  • 1. Cholecystokinin receptor antagonists increase the rat pup's preference toward maternal-odor and rug texture.
    Shayit M; Weller A
    Dev Psychobiol; 2001 Apr; 38(3):164-73. PubMed ID: 11279593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the role of cholecystokinin in appetitive learning in the infant rat.
    Weller A; Tsitolovskya L; Gispan IH; Rabinovitz S
    Peptides; 2001 Aug; 22(8):1317-23. PubMed ID: 11457527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
    Lu L; Zhang B; Liu Z; Zhang Z
    Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CCK(A)-receptor antagonist administered to the neonate alters mother-infant interactions in the rat.
    Weller A; Dubson L
    Pharmacol Biochem Behav; 1998 Apr; 59(4):843-51. PubMed ID: 9586840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.
    Alttoa A; Harro J
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):324-31. PubMed ID: 15163443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
    Wunderlich GR; DeSousa NJ; Vaccarino FJ
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different role of cholecystokinin (CCK)-A and CCK-B receptors in relapse to morphine dependence in rats.
    Lu L; Huang M; Ma L; Li J
    Behav Brain Res; 2001 Apr; 120(1):105-10. PubMed ID: 11173090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.
    Lu L; Huang M; Liu Z; Ma L
    Neuroreport; 2000 Mar; 11(4):829-32. PubMed ID: 10757528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationship study on some nonpeptidal cholecystokinin antagonists.
    Sinha J; Kurup A; Paleti A; Gupta SP
    Bioorg Med Chem; 1999 Jun; 7(6):1127-30. PubMed ID: 10428383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an endogenous cholecystokininergic balance in social memory.
    Lemaire M; Piot O; Roques BP; Böhme GA; Blanchard JC
    Neuroreport; 1992 Oct; 3(10):929-32. PubMed ID: 1421101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subfornical organ: a novel site of action of cholecystokinin.
    Ahmed AS; Dai L; Ho W; Ferguson AV; Sharkey KA
    Am J Physiol Regul Integr Comp Physiol; 2014 Mar; 306(5):R363-73. PubMed ID: 24430886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
    Crawley JN
    J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve.
    Mercer JG; Lawrence CB
    Neurosci Lett; 1992 Mar; 137(2):229-31. PubMed ID: 1374868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory role for CCK-B antagonists in Parkinson's disease.
    Boyce S; Rupniak NM; Tye S; Steventon MJ; Iversen SD
    Clin Neuropharmacol; 1990 Aug; 13(4):339-47. PubMed ID: 1976438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro.
    Xu MY; Yang DX; Wang SZ; Jin HB; Zou XH; Yang XP; Han JS
    Sheng Li Xue Bao; 1998 Aug; 50(4):469-73. PubMed ID: 11324560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK(A) and 5-HT3 receptors interact in anorectic responses to amino acid deficiency.
    Aja SM; Barrett JA; Gietzen DW
    Pharmacol Biochem Behav; 1999 Mar; 62(3):487-91. PubMed ID: 10080241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
    Corwin RL; Smith GP
    Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.
    Lemaire M; Böhme GA; Piot O; Roques BP; Blanchard JC
    Psychopharmacology (Berl); 1994 Aug; 115(4):435-40. PubMed ID: 7871086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
    Lavigne GJ; Millington WR; Mueller GP
    Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.